1 Umanath K, Lewis JB. Update on Diabetic Nephropathy: Core Curriculum 2018. American journal of kidney diseases : the official journal of the National Kidney Foundation 2018;71(6):884-95.
2 Alicic R, Rooney M, Tuttle KJCjotASoNC. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. 2017;12(12):2032-45.
3 Sharma KJA, signaling r. Obesity and Diabetic Kidney Disease: Role of Oxidant Stress and Redox Balance. 2016;25(4):208-16.
4 Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circulation research 2010;107(9):1058-70.
5 Liu Hongyan, Qiao Yufeng, Xue Fuping. New advances in targeted treatment of diabetic nephropathy by intervention oxidative stress pathway. J Chinese Journal of immunology. 2020;36(17):2174-78.
6 Sayed AA, Khalifa M, Abd el-Latif FF. Fenugreek attenuation of diabetic nephropathy in alloxan-diabetic rats: attenuation of diabetic nephropathy in rats. Journal of physiology and biochemistry 2012;68(2):263-9.
7 Abd Jalil A, Khaza'ai H, Nordin N, et al. Vitamin E-Mediated Modulation of Glutamate Receptor Expression in an Oxidative Stress Model of Neural Cells Derived from Embryonic Stem Cell Cultures. Evidence-based complementary alternative medicine 2017;2017:6048936.
8 Yang S, Xiao L, Xu B, et al. Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: a systematic review and meta-analysis. 2014;36(5):722-31.
9 Abdel-Raheem MH, Salim SU, Mosad E, et al. Antiapoptotic and antioxidant effects of carvedilol and vitamin E protect against diabetic nephropathy and cardiomyopathy in diabetic Wistar albino rats. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2015;47(2):97-106.
10 Zhao Y, Zhang W, Jia Q, et al. High Dose Vitamin E Attenuates Diabetic Nephropathy via Alleviation of Autophagic Stress. Frontiers in physiology 2018;9:1939.
11 Bolignano D, Cernaro V, Gembillo G, et al. Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis. PloS one 2017;12(6):e0178699.
12 Aghadavod E, Soleimani A, Hamidi G, et al. Effects of High-dose Vitamin E Supplementation on Markers of Cardiometabolic Risk and Oxidative Stress in Patients with Diabetic Nephropathy: a Randomized Double-blinded Controlled Trial. Iranian journal of kidney diseases 2018;12(3):156-62.
13 Tan GCJ, Tan SMQ, Phang SCW, et al. Tocotrienol-rich vitamin E improves diabetic nephropathy and persists 6-9 months after washout: a phase IIa randomized controlled trial. Therapeutic advances in endocrinology and metabolism 2019;10:2042018819895462.
14 Khatami PG, Soleimani A, Sharifi N, et al. The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial. Journal of clinical lipidology 2016;10(4):922-29.
15 Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes care 2014;37(10):2864-83.
16 Zhao JG, Zeng XT, Wang J, et al. Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis. Jama 2017;318(24):2466-82.
17 Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed) 2011;343:d5928.
18 Puhan MA, Schünemann HJ, Murad MH, et al. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ (Clinical research ed) 2014;349:g5630.
19 Sun YM, Su Y, Li J, et al. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochemical and biophysical research communications 2013;433(4):359-61.
20 Apakkan Aksun S, Ozmen B, Ozmen D, et al. Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration. Journal of diabetes and its complications 2003;17(6):343-8.
21 Yard BA, Kahlert S, Engelleiter R, et al. Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium. Experimental nephrology 2001;9(3):214-22.
22 Ha H, Yu MR, Choi YJ, et al. Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. Journal of the American Society of Nephrology : JASN 2002;13(4):894-902.
23 Li Qiang, An Ying, Sui Chunhong, et al. The role of antioxidants in the progression and treatment of diabetic nephropathy. J Chinese Journal of Integrated Traditional and Western Medicine nephropathy. 2016;17(03):275-76.
24 Fryer MJ. Vitamin E may slow kidney failure owing to oxidative stress. Redox report : communications in free radical research 1997;3(5-6):259-61.
25 Kedziora-Kornatowska K, Szram S, Kornatowski T, et al. Effect of vitamin E and vitamin C supplementation on antioxidative state and renal glomerular basement membrane thickness in diabetic kidney. Nephron Experimental nephrology 2003;95(4):e134-43.
26 Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet (London, England) 2000;356(9237):1213-8.
27 Yang H, Sun N, Li Y, et al. [Regulation of α-tocopherol on NFκB and Nrf2 signaling pathway at early stage of N-nitrosomethylbenzylamine⁃induced human esophageal cell carcinogenesis]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 2015;49(6):546-53.
28 Yang SK, Xiao L, Xu B, et al. Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: a systematic review and meta-analysis. Renal failure 2014;36(5):722-31.